K123248 is an FDA 510(k) clearance for the CPR RSQ ASSIST. Classified as Aid, Cardiopulmonary Resuscitation (product code LIX), Class II - Special Controls.
Submitted by Avantech, Inc. (Philedelphia, US). The FDA issued a Cleared decision on December 10, 2013 after a review of 419 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.
View all Avantech, Inc. devices